Moreover, STAT3 may promote tumor progression by modulating the immune response within tumor microenvironments through several signaling pathways, including S1PR1, JAK, and IL-6 (Wang et al. 2024; Zhong et al. 2024). The gene discussed is S1PR1; the disease is neoplasm.